Phreesia (PHR) traded up 0.65 % during a 24 hours period ending at 06:53 AM Central Europe on Thursday 29th. One Phreesia stock can currently be bought for about USD 12.37 on popular exchanges. Current supply of Phreesia stocks is 62.1 mn. Phreesia has a current market capitalization of USD 756 mn and approximately USD 7.7 mn worth of Phreesia was traded on exchanges in the last 24 hours. Since last month end, Phreesia has traded 23.58 % up. Simple moving average of last 200 days is at USD 10.96. The highest price of past 52 weeks was recorded at USD 23.78 on 10/31/2025. 52 weeks low was at USD 7.77 on 03/31/2026.
Here is how related stocks have performed in the past 24 hours:
Barings Bdc (BBDC) traded up 0.82 % and now trades at USD 8.57. Current market capitalisation for Barings Bdc is USD 893.2 mn. Current price/earnings ratio for Barings Bdc is 10.25.
Monte Rosa Therapeutics (GLUE) traded up 1.78 % and now trades at USD 10.85. Current market capitalisation for Monte Rosa Therapeutics is USD 898.4 mn.
Meiragtx (MGTX) traded up 3.72 % and now trades at USD 9.75. Current market capitalisation for Meiragtx is USD 905.7 mn. Current price/earnings ratio for Meiragtx is 10.03.
Kronos Worldwide (KRO) traded down -0.39 % and now trades at USD 7.7. Current market capitalisation for Kronos Worldwide is USD 895.5 mn.
Obsidian Therapeutics (OBX) traded up 2.39 % and now trades at USD 14.59. Current market capitalisation for Obsidian Therapeutics is USD 893.2 mn.
About Phreesia
Phreesia Inc. is a health care software development company based in New York, United States. The company specializes in providing solutions for appointment scheduling, registration, clinical support, patient surveys, and analysis and report generation. Phreesia aims to serve patients and doctors nationwide in the US. You can find more information about their offerings and initiatives on their website at www.phreesia.com . They are listed on the New York Stock Exchange.